Optic neuritis after mRNA vaccination against COVID-19:a secondary analysis of post-approval national safety data by the Japanese government

作     者：Yudai Kaneda Chiharu Kawasaki Mira Namba Uiri Kaneda Akihiko Ozaki Tetsuya Tanimoto 

作者机构：School of MedicineHokkaido UniversitySapporoHokkaidoJapan Medical Governance Research InstituteMinato-kuTokyoJapan School of MedicineTeikyo UniversityItabashiTokyoJapan School of MedicineKeio UniversityShinjukuTokyoJapan Faculty of Foreign LanguagesDokkyo UniversitySokaSaitamaJapan Department of Breast and Thyroid SurgeryJyoban Hospital of Tokiwa FoundationIwakiFukushimaJapan Department of Internal MedicineJyoban Hospital of Tokiwa FoundationIwakiFukushimaJapan 

出 版 物：《Annals of Eye Science》 (眼科学年鉴（英文）)

年 卷 期：2023年第8卷第1期

页      面：8-11页

学科分类：1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学] 

基　　金：Daiwa Japan Angro-Japan Foundation MNES Inc 

主　　题：vaccination doses Acute 

摘      要：Vaccination is the mainstream measure against coronavirus disease 2019(COVID-19).As of May 2022,more than 80%of the Japanese population has received vaccination doses(1),and booster vaccination programs are in *** disseminated encephalomyelitis is the most common type of demyelination following vaccinations,and although an increase in neuromyelitis optica spectrum disease(NMOSD)has recently been reported worldwide(2-4),no collective data,especially after newly developed mRNA vaccines against COVID-19,have been reported yet.